ERDHEIM-CHESTER DISEASE
Clinical trials for ERDHEIM-CHESTER DISEASE explained in plain language.
Never miss a new study
Get alerted when new ERDHEIM-CHESTER DISEASE trials appear
Sign up with your email to follow new studies for ERDHEIM-CHESTER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
UK trial repurposes melanoma drugs to fight rare cancers
Disease control Recruiting nowThis trial is testing if a combination of two drugs, already approved for a type of skin cancer, can help control other rare cancers that share the same genetic change (a BRAF V600 mutation). It aims to enroll 30 adult patients with various rare or uncommon cancers to see if the …
Matched conditions: ERDHEIM-CHESTER DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for Tough-to-Treat rare diseases: experimental drug targets faulty cell signals
Disease control Recruiting nowThis study is testing whether the drug cobimetinib can help control several rare disorders caused by overactive immune cells, particularly when standard treatments have failed. The trial will enroll 90 children and adults with conditions like Langerhans cell histiocytosis (LCH) a…
Matched conditions: ERDHEIM-CHESTER DISEASE
Phase: PHASE2 • Sponsor: Carl Allen • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Doctors launch major study to track rare disease Patients' journeys
Knowledge-focused Recruiting nowThis study aims to create a registry to better understand Erdheim-Chester disease and related rare conditions. Researchers will collect health information from 500 participants to learn how these diseases affect people's lives and how different treatments work over time. Some par…
Matched conditions: ERDHEIM-CHESTER DISEASE
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC
-
New scan seeks to illuminate hidden cancers
Knowledge-focused Recruiting nowThis study is testing a new imaging agent used with PET/CT scans to see if it can better detect and measure certain blood cancers and rare tumors. It involves about 30 adult patients with conditions like non-Hodgkin lymphoma, multiple myeloma, or specific rare diseases. The goal …
Matched conditions: ERDHEIM-CHESTER DISEASE
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC